Custom border rules take effect today to block gray market Canadian drug imports

U.S. Customs and Border Protection implemented strict new electronic entry requirements today aimed at halting personal importations of brand-name prescription drugs across the Canadian border. Under the updated customs enforcement framework, international mail shipments lacking formal importer of record documentation face immediate confiscation, closing a long standing gray market loophole relied on by millions of American consumers.

The border enforcement tightening marks a sharp policy reversal from federal initiatives designed to expand access to lower cost foreign pharmaceuticals. In September 2020, federal regulators approved state level import plans allowing Florida and other local jurisdictions to procure bulk prescription drugs directly from Canadian distributors to curb domestic healthcare spending.

https://www.peoplespharmacy.com/articles/prescription-panic-will-canadian-drug-imports-stop-on-october-22